Development of an antipeptide antibody that binds to the C-terminal region of human CYP1B1

Drug Metabolism and Disposition

Volumn 27, Issue 2, 1999, Pages 274-280

  Tang, Yong Ming ^a   Chen, Gen Fu ^a   Thompson, Patricia A ^a   Dong Xin, Lin ^c   Lang, Nicholas P ^b   Kadlubar, Fred F ^a   Tang, George Y ^d  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d Natl Ctr Toxicological Res F   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; PEPTIDE ANTIBODY;

ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS REACTION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; TITRIMETRY;

AMINO ACID SEQUENCE; ANTIBODIES; ANTIBODY SPECIFICITY; ARYL HYDROCARBON HYDROXYLASES; CELL LINE; CROSS REACTIONS; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; IMMUNOBLOTTING; MICROSOMES; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; PEPTIDE FRAGMENTS; PRECIPITIN TESTS;

ANIMALIA; ORYCTOLAGUS CUNICULUS; RODENTIA;

EID: 0345390836     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Anderson DJ and Blobel G (1983) Immunoprecipitation of protein from cell-free translations. Methods Enzymol 96:111-120.
2. Bermatowicz MS and Matsuedon GR (1986) Preparation of peptide-protein immunogens using N-succinimidyl bromoacetate as a heterobifunctional crosslinking reagent. Anal Biochem 155:95-102.
3. Brake PB and Jefocoate CR (1995) Regulation of cytochrome P-4501B1 in cultured rat adrenocortical cells by cyclic adenosine 3′,5′-monophosphate and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Endocrinology 136:5034-5041.
4. Christou MK, Keith IM, Shen X, Schroeder E and Jefcoate CR (1993) Reversal of cytochrome P-4501 A1 and P-450-EF expression in MCA-C3H/10T1/2 cell-derived tumors as compared to cultured cells. Cancer Res 53:968-976.
5. Christou MK, Savas U, Spink DC, Gierthy JF and Jefcoate CR (1994) Co-expression of human CYP1A1 and a human analog of cytochrome P-450-EF in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the human mammary carcinoma-derived MCF-7 cells. Carcinogenesis 15:725-732.
6. Cooper HM and Peterson Y (1994) Antibody detection and preparation, in Current Protocols in Immunologv (Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM and Strober W eds) p 2.4.8, John Wiley & Sons, New York.
7. Crespi CL, Penman BW, Steimel DT, Smith T, Yang CS and Sutter TR (1997) Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: Substrate specificity with model substrates and promutagens. Mutagenesis 12:83-89.
8. Edwards RJ, Adams DA, Watts PS, Davies DS and Boobis AR (1998) Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P-450 in humans. Biochem Pharmacol 59:377-387.
9. Edwards RJ, Murray BP, Boobis AR and Davies DS (1989) Identification and location of α-helices in mammalian cytochromes P450. Biochemistry 28:3762-3770.
10. Edwards RJ, Murray BP, Singleton AM, Murray S, Davies DS and Boobis AR (1993) Identification of the epitope of an anti-peptide antibody which binds to CYP1A2 in many species including man. Biochem Pharmacol 46:213-220.
11. Edwards RJ, Singleton AM, Murray BP, Sesardic D, Rich KJ, Murray S, Davies DS and Boobis AR (1990) An anti-peptide antibody targeted to a specific region of rat cytochrome P-4501A2 inhibits enzyme activity. Biochem J 266:497-504.
12. Gonzalez F (1988) The molecular biology of cytochrome P450s. Pharmacol Rev 40:243-288.
13. Guengerich FP (1994) Analysis and characterization of enzymes, in Principles and Methods of Toxicology (Hayes AW ed) 3rd ed., pp 1259-1313, Raven Press, New York.
14. Guengerich FP (1995) Human Cytochrome P-450 Enzymes. In Cytochrome P450, Structure, Mechanism, and Biochemistry (Ortiz De Montellano PR ed) 2nd ed., pp 473-535, Plenum Press, New York.
15. Hakkola J, Pasanen M, Pelkonen O, Hukkanen J, Evisalmi S, Anttila S, Rane A, Mantyla M, Purkunen R, Saarikoski S, Tooming M and Raunio H (1997) Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis 18:391-397.
16. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ and Sutter TR (1996) 17β-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 93:9776-9781.
17. Huang ZQ, Fasco MJ, Figge HL, Keyomarsi K and Kaminsky LS (1996) Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab Dispos 24:899-905.
18. Jaiswal AK, Gonzalez FJ and Nebert DW (1985) Human dioxin-inducible cytochrome P1-450: Complementary DNA and amino acid sequence. Science (Wask DC) 228:80-83.
19. Jaiswal AK, Nebert DW, McBride OW and Gonzalez FJ (1987) Human P(3)450: cDNA and complete protein sequence, repetitive Alu sequences in the 3′ nontranslated region, and localization of gene to chromosome 15. J Exp Pathol 3:1-17.
20. Kessler SW (1975) Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: Parameters of the interaction of antibody-antigen complexes with protein A. J Immunol 115:1617-1624.
21. Liehr JG and Ricci MJ (1996) 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 93:3294-3296.
22. Liehr JG, Ricci MJ, Jefcoate CR, Hannigan EV, Hokanson JA and Zhu BT (1995) 4-hydroxylation of estradiol by human uterine myometrium and myoma microsomes: Implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci USA 92:9220-9224.
23. McKay JA, Melvin WT, Ah-See AK, Ewen SW, Greenlee WF, Marcus CB, Burke MD and Murray GI (1995) Expression of cytochrome P450 CYP1B1 in breast cancer. FEBS Lett 374:270-272.
24. Murray GI, Taylor MC, McFadyen MCE, McKay JA, Greenlee WF, Burke MD and Melvin WT (1997) Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57:3026-3031.
25. Pottenger LH, Christou M and Jefcoate CR (1991) Purification and immunological characterization of a novel cytochrome P450 from C3H/10T1/2 cells. Arch Biochem Biophys 286:488-497.
26. Poulos TL, Finel BC, Gunsalus IC, Wagner GC and Kraut J (1986) The 2.6-A crystal structure of pseudomonas putida cytochrome P-450. J Biol Chem 260:16122-16130.
27. Savas U, Bhattacharyya KK, Christou M, Alexander DL and Jefcoate CR (1994) Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. J Biol Chem 269:14905-14911.
28. Schweikl H, Taylor JA, Kitareewan S, Linko P, Nagomey D and Goldstein A (1993) Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics 3:239-249.
29. Shen S and Strobel HW (1995) Functional assessment of specific amino acid residues of cytochrome P4501A1 using anti-peptide antibodies. Arch Biochem Biophys 320:162-169.
30. Shimada T, El-Bayoumy K, Upadhyaya P, Sutter TR, Guengerich FP and Yamazaki H (1997) Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds. Cancer Res. 57:4757-4764.
31. Shimada T, Hayes CL, Yamazaki H, Amin A, Hecht S, Guengerich FP and Sutter TR (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 56:2979-2984.
32. Spink DC, Eugster HP, Lincoln DW, Schuetz JD, Schuetz EG, Johnson JA, Kaminsky LS and Gierthy JF (1992) 17-Estradiol hydroxylation catalyzed by human cytochrome P450 1A1: A comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch Biochem Biophys 293:342-348.
33. Spink DC, Spink BC, Cao JQ, Gierthy JF, Hayes CL, Li Y and Sutter TR (1997) Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells. J Steroid Biochem Mol Biol 62:223-232.
34. Stefan K and Greenlee WF (1997) Cell-specific regulation of human CYP1A1 and CYP1B1 gene. Cancer Res 57:1264-1269.
35. Sutter TR, Tang YM, Hayes CL, Wo YP, Jabs EW, Li X, Yin H, Cody CW and Greenlee WF (1994) Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 269:13092-13099.
36. Tang YM, Wo YP, Stewart J, Hawkins AL, Griffin CA, Sutter TR and Greenlee WF (1996) Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J Biol Chem 271:28324-28330.
37. Vadlamuri SV, Glover DD, Turner T and Sarkar MA (1998) Regiospecific expression of cytochrome P4501A1 and 1B1 in human uterine tissue. Cancer Lett 122:143-150.
38. Walker NJ, Gastel JA, Costa LT, Clark GC, Lucier GW and Sutter TR (1995) Rat CYP1B1: An adrenal cytochrome P450 that exhibits sex-dependent expression in livers and kidneys of TCDD-treated animals. Carcinogenesis 16:1319-1327.
39. Wang RW and Lu AYH (1997) Inhibitory anti-peptide antibody against human CYP3A4. Drug Metab Dispos 25:762-767.
40. Yamazaki H, Shaw PM, Guengerich FP and Shimada T (1998) Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol 11:659-665.